Add BrightSurf on Google Email

Johns Hopkins Medicine


Why people with diabetes can't buy generic insulin

A Johns Hopkins study reveals that drug companies have extended patents on insulin for over 90 years, preventing generic versions from entering the market. This has led to costly treatment options, with prices ranging from $120 to $400 per month, and hospitalizations due to uncontrolled diabetes.

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateMar 18, 2015

Finding strengths -- and weaknesses -- in hepatitis C's armor

Researchers have identified tiny differences in the outer shell proteins of different hepatitis C viruses that make them resistant to antibodies. The study found that these protein variations are not located where antibodies attach, requiring multiple antibodies to be stimulated for an effective vaccine. Future research will focus on i...

SourceJohns Hopkins Medicine·JournalJournal of Clinical Investigation·DateMar 11, 2015

Ensuring respect and dignity in the ICU

Researchers at Johns Hopkins have developed a conceptual model defining three sources of patient dignity: shared humanity, personal narrative, and autonomy. The study identifies four consensus areas relevant to treatment with respect and dignity in the ICU, including treating patients as human beings, unique individuals, and entitled t...

SourceJohns Hopkins Medicine·JournalNarrative Inquiry in Bioethics·DateMar 10, 2015

Johns Hopkins researchers engineer custom blood cells

Scientists have made a breakthrough in treating patients with sickle cell disease by engineering custom blood cells that can evade the immune system. Lab-grown stem cells were reprogrammed and edited using CRISPR to replace the defective gene, resulting in healthy red blood cells that function just as well as those from unaffected donors.

SourceJohns Hopkins Medicine·JournalStem Cells·DateMar 9, 2015

Competition among physicians and retail clinics drive up antibiotic prescribing rate

A study by Johns Hopkins researchers found that competition among healthcare providers, including physicians and retail clinics, leads to higher antibiotic prescribing rates in affluent areas. The analysis revealed a strong correlation between the number of clinics and increased antibiotic prescriptions in wealthy regions.

SourceJohns Hopkins Medicine·JournalJournal of Antimicrobial Chemotherapy·DateFeb 25, 2015

Most clinical 'calculators' over-estimate heart attack risk

A new study by Johns Hopkins Medicine reveals that four out of five widely used clinical calculators significantly overestimate the likelihood of a heart attack. The researchers found that these algorithms calculate heart attack probability using factors such as gender, age, smoking history, and cholesterol levels, but may not accurate...

SourceJohns Hopkins Medicine·JournalAnnals of Internal Medicine·DateFeb 16, 2015

Under pressure

Researchers found that receiving cells respond to pressure on their membranes by stiffening their skeletons to prevent movement away from the attacking cell. This process allows for close proximity of cell membranes, enabling fusion to occur.

SourceJohns Hopkins Medicine·JournalDevelopmental Cell·DateFeb 12, 2015

Coral snake venom reveals a unique route to lethality

Researchers discovered that coral snake venom's toxins permanently activate crucial nerve cell proteins, preventing reset and causing deadly seizures. The toxins target GABA(A) receptors, making them 100 times tighter than known compounds, leading to permanent opening of the receptor's pore.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateFeb 9, 2015

State-of-the-science help for hay fever sufferers

Hay fever sufferers can benefit from state-of-the-science treatments like sublingual immunotherapy. The American Academy of Otolaryngology recommends this treatment for patients with specific allergies who don't respond to other treatments, with a completion period of up to five years. Other key recommendations include diagnosing and t...

Time to rethink the inner-city asthma epidemic?

A new study from Johns Hopkins Medicine reveals that urban living is not a significant risk factor for asthma, instead highlighting the importance of poverty, African-American race, and Puerto Rican ethnicity as potent predictors. The research found no differences in asthma rates between children living in urban areas and their suburba...

SourceJohns Hopkins Medicine·JournalJournal of Allergy and Clinical Immunology·DateJan 20, 2015

Mutations linked to repair of chromosome ends may make emphysema more likely in smokers

A new study found that mutations in the telomerase reverse transcriptase (TERT) gene increase the risk of emphysema in smokers. Female smokers with these mutations may be more susceptible to the disease. The researchers also discovered a link between telomere shortening and other health problems, such as osteoporosis and liver disease.

SourceJohns Hopkins Medicine·JournalJournal of Clinical Investigation·DateJan 14, 2015

When DNA gets sent to time-out

A team of researchers from Johns Hopkins Medicine has discovered a specific sequence and protein tags that send DNA to the edge of the nucleus, where its genes get turned off. This process is crucial for controlling genes and determining cell fate, particularly during development.

SourceJohns Hopkins Medicine·JournalJournal of Cell Biology·DateJan 6, 2015

New treatment strategy allows lower doses of toxic tuberculosis drug without compromising potency

Researchers at Johns Hopkins Medicine have developed a new treatment strategy that allows lower doses of the toxic tuberculosis drug bedaquiline to retain potency while reducing side effects. This approach, which combines bedaquiline with verapamil, has shown promising results in mouse studies and is poised for clinical trials.

SourceJohns Hopkins Medicine·JournalAntimicrobial Agents and Chemotherapy·DateDec 30, 2014